These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 27287409)

  • 1. Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.
    Zhao J; Zhao J; Mangalam AK; Channappanavar R; Fett C; Meyerholz DK; Agnihothram S; Baric RS; David CS; Perlman S
    Immunity; 2016 Jun; 44(6):1379-91. PubMed ID: 27287409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
    Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
    J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide B Cell, CD4
    Prakash S; Srivastava R; Coulon PG; Dhanushkodi NR; Chentoufi AA; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Buchmeier MJ; Bouziane M; Nesburn AB; Kuppermann BD; BenMohamed L
    J Immunol; 2021 Jun; 206(11):2566-2582. PubMed ID: 33911008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
    Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.
    Liu WJ; Zhao M; Liu K; Xu K; Wong G; Tan W; Gao GF
    Antiviral Res; 2017 Jan; 137():82-92. PubMed ID: 27840203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection.
    Ng OW; Chia A; Tan AT; Jadi RS; Leong HN; Bertoletti A; Tan YJ
    Vaccine; 2016 Apr; 34(17):2008-14. PubMed ID: 26954467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induced disease in susceptible and resistant hosts.
    Khanolkar A; Fulton RB; Epping LL; Pham NL; Tifrea D; Varga SM; Harty JT
    J Immunol; 2010 Jul; 185(2):1132-41. PubMed ID: 20554960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen.
    Yang L; Peng H; Zhu Z; Li G; Huang Z; Zhao Z; Koup RA; Bailer RT; Wu C
    J Gen Virol; 2007 Oct; 88(Pt 10):2740-2748. PubMed ID: 17872527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein.
    Zhao K; Yang B; Xu Y; Wu C
    Vaccine; 2010 Sep; 28(41):6666-74. PubMed ID: 20709007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses.
    Huang J; Ma R; Wu CY
    Vaccine; 2006 Jun; 24(23):4905-13. PubMed ID: 16621188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection.
    Du L; Zhao G; Lin Y; Chan C; He Y; Jiang S; Wu C; Jin DY; Yuen KY; Zhou Y; Zheng BJ
    Vaccine; 2008 Mar; 26(13):1644-51. PubMed ID: 18289745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes.
    Liu J; Sun Y; Qi J; Chu F; Wu H; Gao F; Li T; Yan J; Gao GF
    J Infect Dis; 2010 Oct; 202(8):1171-80. PubMed ID: 20831383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
    Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
    J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad and strong memory CD4
    Peng Y; Mentzer AJ; Liu G; Yao X; Yin Z; Dong D; Dejnirattisai W; Rostron T; Supasa P; Liu C; López-Camacho C; Slon-Campos J; Zhao Y; Stuart DI; Paesen GC; Grimes JM; Antson AA; Bayfield OW; Hawkins DEDP; Ker DS; Wang B; Turtle L; Subramaniam K; Thomson P; Zhang P; Dold C; Ratcliff J; Simmonds P; de Silva T; Sopp P; Wellington D; Rajapaksa U; Chen YL; Salio M; Napolitani G; Paes W; Borrow P; Kessler BM; Fry JW; Schwabe NF; Semple MG; Baillie JK; Moore SC; Openshaw PJM; Ansari MA; Dunachie S; Barnes E; Frater J; Kerr G; Goulder P; Lockett T; Levin R; Zhang Y; Jing R; Ho LP; ; ; Cornall RJ; Conlon CP; Klenerman P; Screaton GR; Mongkolsapaya J; McMichael A; Knight JC; Ogg G; Dong T
    Nat Immunol; 2020 Nov; 21(11):1336-1345. PubMed ID: 32887977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
    Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
    J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Basis of Coronavirus Virulence and Vaccine Development.
    Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I
    Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-mediated immune response to respiratory coronaviruses.
    Channappanavar R; Zhao J; Perlman S
    Immunol Res; 2014 Aug; 59(1-3):118-28. PubMed ID: 24845462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients.
    Peng H; Yang LT; Wang LY; Li J; Huang J; Lu ZQ; Koup RA; Bailer RT; Wu CY
    Virology; 2006 Aug; 351(2):466-75. PubMed ID: 16690096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
    Reche PA
    Front Immunol; 2020; 11():586984. PubMed ID: 33178220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
    Zhi Y; Kobinger GP; Jordan H; Suchma K; Weiss SR; Shen H; Schumer G; Gao G; Boyer JL; Crystal RG; Wilson JM
    Virology; 2005 Apr; 335(1):34-45. PubMed ID: 15823604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.